Metabolic Diseases Terminated Phase 1 / 2 Trials for Losartan (DB00678)

Also known as: Diseases, Metabolic / Metabolic Disease

IndicationStatusPhase
DBCOND0030621 (Metabolic Diseases)Terminated1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00467831Pilot Study of a Multi-Drug Regimen for Severe Pulmonary Fibrosis in Hermansky-Pudlak SyndromeTreatment